Rabbit Polyclonal CLCA4 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 7 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CLCA4.
View Alternative Names
CaCC2, UNQ562/PRO1124, CLCA4, Calcium-activated chloride channel regulator 4, Calcium-activated chloride channel family member 4, Calcium-activated chloride channel protein 2, Chloride channel accessory 4, hCLCA4, CaCC-2, hCaCC-2
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CLCA4 antibody (AB197347)
Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue sections labeling CLCA4 with ab197347 at 1/10 dilution.
- WB
Supplier Data
Western blot - Anti-CLCA4 antibody (AB197347)
Gel : 8%SDS-PAGE.
All lanes:
Western blot - Anti-CLCA4 antibody (ab197347) at 1/200 dilution
All lanes:
293T cell lysate at 40 µg
Secondary
All lanes:
Anti-rabbit IgG at 1/8000 dilution
Predicted band size: 101 kDa
false
Exposure time: 30s
- WB
CiteAb
Western blot - Anti-CLCA4 antibody (AB197347)
CLCA4 western blot using anti-CLCA4 antibody ab197347. Publication image and figure legend from Liu, Z., Chen, M., et al., 2018, Aging (Albany NY), PubMed 30312171.
ab197347 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab197347 please see the product overview.
CLCA4expression was correlated with the expression of epithelial-mesenchymal transition (EMT) markers. (A) Serial sections of human HCC tissue were subjected to IHC staining with antibodies against CLCA4, E-cadherin, Vimentin and N-cadherin. In patient #1, low CLCA4 expression in HCC tissues was accompanied by the absence of E-cadherin and elevated Vimentin, N-cadherin. In patient #2, high CLCA4 expression was accompanied by elevated E-cadherin and the absence of Vimentin, N-cadherin. The scale bar represents 50 μm. (B) CLCA4 expression was positively associated with E-cadherin expression and negatively correlated with vimentin and N-cadherin expression. (C) Decreased expression of E-cadherin with increased expression of Vimentin and N-cadherin in CLCA4-silenced cells compared with the control cells. An opposite expression pattern of these genes was observed in CLCA4-transfected cells. (D) The mRNA of E-cadherin was down-regulated, while the vimentin and N-cadherin was up-regulated, when CLCA4 was silenced. And opposite expression was observed in CLCA4-transfected cells.
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Cells 14: PubMed39996749
2025
Applications
Unspecified application
Species
Unspecified reactive species
European journal of histochemistry : EJH 66: PubMed35266369
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell international 21:549 PubMed34663338
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Nucleic acids 24:113-126 PubMed33738143
2021
Applications
Unspecified application
Species
Unspecified reactive species
Medical science monitor : international medical jo 25:4176-4185 PubMed31164625
2019
Applications
Unspecified application
Species
Unspecified reactive species
Aging 10:2570-2584 PubMed30312171
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 8:93001-93013 PubMed29190973
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com